OPDP Issues First Regulatory Action Letter of 2022
Eye on FDA
JANUARY 26, 2022
According to the letter, the agency noted first of all that the video that was part of the Instagram post stated that Trulicity could “lower A1C along with diet and exercise” but that the Medication Guide specifically states that the drug is used for people with type 2 diabetes. So why did OPDP act upon this Instagram post?
Let's personalize your content